Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 10, 2023 - Pfizer announced the FDA approval of Zavzpret (zavegepant), for the acute treatment of migraine with or without aura in adults.
Download PDF
Return to publications
